Management of non-communicable disease patients during the COVID-19 pandemic

Abstract: The coronavirus disease 2019 (COVID-19) pandemic has posed significant challenges in management of non-communicable diseases (NCDs), including cardiovascular diseases, diabetes, and respiratory illnesses. Patients with NCDs are particularly vulnerable to severe outcomes, if infected with COVID-19, making timely and effective management crucial. The pandemic has disrupted routine healthcare service delivery, limiting access to essential care/medications, and monitoring, which leads to exacerbation of symptoms/severity/complications of these chronic conditions. Telemedicine has emerged as a vital tool, allowing healthcare providers to offer consultations and manage treatment plans remotely. However, the transition to virtual care has its challenges, including issues related to technology access, digital literacy, and maintaining the quality of care. The pandemic has highlighted disparities in healthcare, as patients in low-resource settings face even greater difficulties in managing their conditions, whilst their higher risk of exposure to COVID-19 infection, and its negative effects on their current health status. Strategies to address negative influence of the pandemic on patients with noncommunicable diseases include improving telehealth infrastructure, ensuring availability of medications, and focusing on patient education to promote self-management. Overall, the pandemic has underscored the need for resilient healthcare systems that can adapt the demands of a global health crisis, without compromising the needs of NCD patients.